Antibiotic Development Strategies to Understand and Label Microbial Endpoints such as Slow killing, resistance and Failure, AUIC Dosing and Success via Synergy
Jerome J. Schentag, PharmD
University at Buffalo
Buffalo, New York
Schentag@buffalo.edu
Next slide
Back to first slide
View graphic version